Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
about
Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasisAn integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionBRCA1 is a negative modulator of the PRC2 complexDAB2IP in cancerDab2IP GTPase activating protein regulates dendrite development and synapse number in cerebellumPrognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysisThe interactome of a PTB domain-containing adapter protein, Odin, revealed by SILACTumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.A genome-wide DNA methylation study in colorectal carcinoma.Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosisSlug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancerASK-ing EMT not to spread cancer.Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy.Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells and increases their cloning efficiency.Negative regulation of DAB2IP by Akt and SCFFbw7 pathwaysA common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males.Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration.Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancerSensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerRare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression networkA small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.Epithelial mesenchymal transition (EMT) in prostate growth and tumor progressionThe role of epithelial plasticity in prostate cancer dissemination and treatment resistanceCisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.Radiosensitization in prostate cancer: mechanisms and targetsEpigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer.Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cellsDownregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumorsAIP1 prevents graft arteriosclerosis by inhibiting interferon-γ-dependent smooth muscle cell proliferation and intimal expansionEpigenetics in prostate cancer.Expression of mouse Dab2ip transcript variants and gene methylation during brain development.Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.
P2860
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
P248
Q21245487-BE0BF0AF-8798-4853-978E-164A71CC16F6Q24313269-8F02DC23-B639-401A-B2B1-673828A0ECDBQ24339430-90843492-A155-4F1B-9CC8-A5E0AAB5CD62Q26776456-74D6BFF1-327E-42C8-B041-0E662A7AC9E7Q27321121-C9860EE6-457D-4624-AF19-9464F909D0CCQ28076962-5AA5E0DE-630B-4676-A453-4CB4A9D72CA8Q30155954-37165664-DC34-4CE7-BDDD-58AFAC3DD239Q30822011-7444950C-1430-417D-8E63-A803FC9EA3B4Q31020320-F29F0137-F695-4817-BE45-9E01867DEE98Q33351622-D40A39AF-7BA1-4C21-A76A-7A467F68C8F5Q33586771-179DDEF1-28C0-4086-B7EC-9016FDDD0D98Q33636318-2EBF2122-5B20-42B7-8EFE-3A5DFB0985B2Q33733916-96567C5C-D094-4556-AB71-F58118C6A6CBQ33774874-BCB77E5D-9745-41F6-8EC4-81F2B5E66363Q33775723-52526A42-7E69-4377-ABD2-C0F11DC4A274Q33862490-935B2B61-8039-4793-B102-D5EAAD46CE81Q33917635-638DEB4F-7F3B-47FD-9DED-A049E51D51ACQ34064865-6ED6FB95-331C-4133-B67A-4220424FA64AQ34072491-D4A1B419-2334-4D39-92D5-86D8703420B6Q34197861-59DD0AC7-D04D-43C8-A1F7-452663A4B5B0Q34221837-59A2734B-09CC-48B6-ABF5-6585420248A2Q34227747-32D7F716-352C-4F50-996B-6E47B2E10F7CQ34295621-E19DAF11-BA83-42C1-8544-7E38ACE4E330Q34318239-D1E76893-E186-40A4-AE3B-8F802E7C9761Q34390813-63A3911D-AF10-4A3E-AAB7-BC6DC923FBA3Q34397291-1A44DABF-0127-4F7A-B44B-B47EBE1321E1Q34505037-FDB10D26-AE63-46DF-9CC7-7DAFD006C6B6Q34515582-B0A52337-3DCC-47BE-8C87-D647E07573B1Q34563981-F00E9E11-4C33-4F9C-84A0-232DCCEFEA18Q34897761-630D6C52-684B-47DD-8CCD-7A836F539C31Q35000947-D03D1403-D819-43F2-A929-208CC1CDBBCDQ35024079-04BFF21E-AB4E-48F3-9A2A-C6AB17EE1DEDQ35051774-082DF38F-7802-431C-B69E-1BD118FAFE8AQ35070139-B1DB193F-C0C1-4B8A-8FC8-5B89D49C3AB8Q35221554-37FA42F3-C831-4B84-A4CF-0C7418A1EEA9Q35551005-27B8665D-39D4-4B28-9195-77DB9BEA4A70Q35582538-4A5BD664-50D7-4DAF-83DC-117F3BAAB805Q35608952-38948E75-A624-4B2D-A0AD-C83110972263Q35759432-3266A39D-B8EE-454F-90CF-F7BF9FF4E0F3Q35769839-5FE9CB4B-E07A-4F8B-AE69-3BCABC025E65
P2860
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of DAB2IP in modulating e ...... and prostate cancer metastasis
@nl
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@ast
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en-gb
type
label
Role of DAB2IP in modulating e ...... and prostate cancer metastasis
@nl
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@ast
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en-gb
prefLabel
Role of DAB2IP in modulating e ...... and prostate cancer metastasis
@nl
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@ast
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en-gb
P2093
P2860
P921
P3181
P356
P1476
Role of DAB2IP in modulating e ...... nd prostate cancer metastasis.
@en
P2093
Crystal Gore
David A Boothman
Daxing Xie
Guiyang Hao
Haifeng Zhang
Jer-Tsong Hsieh
Michael Long
P2860
P304
P3181
P356
10.1073/PNAS.0908133107
P407
P50
P577
2010-01-13T00:00:00Z